Filing Details

Accession Number:
0001193805-14-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-02 06:41:04
Reporting Period:
2013-12-16
Filing Date:
2014-01-02
Accepted Time:
2014-01-02 06:41:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438533 Retrophin Inc. RTRX Pharmaceutical Preparations (2834) 262383102
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1525354 Martin Shkreli C/O Retrophin, Inc.
777 Third Avenue, 22Nd Floor
New York NY 10017
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-31 150,000 $7.00 2,816,246 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.0001 Per Share Employee Stock Option (Right to Buy) Acquisiton 2013-12-16 1,080,000 $0.00 1,080,000 $7.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,080,000 2023-12-16 No 4 A Direct
Footnotes
  1. In accordance with the terms of privately-negotiated transactions, the Reporting Person is required to pay the Sellers of such shares $7.00 per share of the Issuer's common stock, subject to adjustments under certain circumstances.
  2. The option vests in twelve equal installments on the last day of each calendar quarter beginning on December 31, 2013.